This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

mRNA Applications and Therapeutics
23 March 2022
1-Day Digital Event // Powered by AQMEN365Begins at 12:00PM GMT
23 March 2022
1-Day Digital Event // Powered by AQMEN365,
Begins at 12:00PM GMT

AQMEN365 // Highly Focused Topics Delivered in a Digital Format

Navigate the rapidly growing mRNA market with highly-targeted updates from industry pioneers

Critical insights into gene editing, regulation, future market trends, and technology advancements - paving the way for the future of mRNA applications and therapies

The Next Generation of mRNA is here: Don't Get Left Behind

The Future of mRNA Vaccines

With the success of the covid vaccine, mRNA vaccines are to be used and developed for further use and treatment of more common and less common infections and other illnesses. Join key players including the likes of eTheRNA Immunotherapies as they provide critical updates on the current and future state of the industry.

Join your peers this March to learn about what the future of vaccines could look like with the use of mRNA and be a part of the industry-shaping discussions.

Personalised Treatments with mRNA

Take a detailed dive into the exciting breakthrough research that shows a promising future for personalised cancer therapy. Learn from the pioneering companies, such as Moderna, who are paving the way for effective mRNA application. This form of treatment is the next big step towards targeted and specialist patient treatment. Tune into sessions that will explore this application further and discuss novel approaches to increase the success of cancer therapies.

Development of mRNA Technology

The technology used to help with mRNA development is always improving. Develop your understanding of the best technologies and what works most effectively to help with manufacturing and other stages of mRNA development. Get one-step ahead of the competition with insights on the advancement of mRNA technology from key technology providers in the field, with speakers from BIA Separations and CRB Group.

AQMEN365: PROGRESSIVE, INSIGHTFUL, EXCLUSIVELY DIGITAL

AQMEN365 events are designed to help you cut through the noise and engage with the content that is critical to your development. Expect short-form digital events packed with detailed insights to help you elevate your knowledge in an impactful way.

Tailored Networking

Surround yourself with truly like-minded individuals who are influencing the part of the industry that is specific to you and your role. Swap tips and business cards with the leaders in mRNA research and technology on our best-in-class digital event platform. This is your chance to position yourself as a thought-leader and develop your skills even further with the who's who in the mRNA industry.

Big Ideas with Great Value

AQMEN365 events allow you to obtain the key updates you require at an extremely affordable rate. Obtain the critical updates specific to your research and company objectives coupled with the opportunities to meet with thought-leaders in the field - opening up easily-accessible learning opportunities like never before.

Speed and Ease

Traveling is not always the best option, especially when key projects are in progress. Now you'll be able to support your research armed with the latest tools and knowledge required for success - without the time-commitment that comes with in-person events. Truly tailored to the time-short leaders in industry, with AQMEN365 you can weave your learning opportunities within your day-to-day schedule.

Who should attend?

CSOs/CMOs
Directors of Vaccines and Infectious Diseases
Senior Scientists
Marketing Development Managers
Heads of Formulation and Delivery
R&D Professionals

PUT YOURSELF IN FRONT OF HIGHLY-TARGETED KEY BUYERS IN THE MRNA INDUSTRY

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals. Get in touch with us to discover how you can leverage your company's offering to thought-leaders and key buyers within the mRNA field.

Contact Michael Dunnet: MDunnet@informaconnectls.com | +1 (617) 960-6173